05:40 AM EDT, 07/14/2025 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday it appointed Christopher Stevens as chief operating officer, effective July 7, replacing Kinnari Patel, who transitioned to president and head of research and development.

Stevens most recently served as executive vice president and chief patient supply officer of Spark Therapeutics, according to a regulatory filing.